{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:47:58Z","timestamp":1785908878461,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.7759\/cureus.113973","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:08:58Z","timestamp":1785906538000},"source":"Crossref","is-referenced-by-count":0,"title":["Procalcitonin-Guided Strategies for Reducing Antibiotic Use in CAP, HAP, VAP, and COPD: Insights From a Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Vivek","family":"Nangia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.2174\/1573398X14666180601073756","article-title":"Utility of procalcitonin in the management of hospital-acquired pneumonia - a review","volume":"14","author":"Kumar S","year":"2018","unstructured":"Kumar S, Jan RA, Rasool R, Fomda BA, Koul PA. Utility of procalcitonin in the management of hospital-acquired pneumonia - a review. Curr Respir Med Rev. 2018, 14:42-7.","journal-title":"Curr Respir Med Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.03.050","article-title":"Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED","volume":"36","author":"Zhou H","year":"2018","unstructured":"Zhou H, Guo S, Lan T, Ma S, Zhang F, Zhao Z. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED. Am J Emerg Med. 2018, 36:2155-60. 10.1016\/j.ajem.2018.03.050","journal-title":"Am J Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.01978.x","article-title":"Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia","volume":"16","author":"Long W","year":"2011","unstructured":"Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Respirology. 2011, 16:819-24. 10.1111\/j.1440-1843.2011.01978.x","journal-title":"Respirology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17509950","article-title":"Bacteria, antibiotics and COPD","volume":"17","author":"Wilson R","year":"2001","unstructured":"Wilson R. Bacteria, antibiotics and COPD. Eur Respir J. 2001, 17:995-1007. 10.1183\/09031936.01.17509950","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz520","article-title":"Host inflammatory biomarkers of disease severity in pediatric community-acquired pneumonia: a systematic review and meta-analysis","volume":"6","author":"Fernandes CD","year":"2019","unstructured":"Fernandes CD, Arriaga MB, Costa MC, et al.. Host inflammatory biomarkers of disease severity in pediatric community-acquired pneumonia: a systematic review and meta-analysis. Open Forum Infect Dis. 2019, 6:ofz520. 10.1093\/ofid\/ofz520","journal-title":"Open Forum Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(11)17","article-title":"Biomarkers in community-acquired pneumonia: a state-of-the-art review","volume":"67","author":"Seligman R","year":"2012","unstructured":"Seligman R, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Pacheco EF, Dalla Rosa K. Biomarkers in community-acquired pneumonia: a state-of-the-art review. Clinics (Sao Paulo). 2012, 67:1321-5. 10.6061\/clinics\/2012(11)17","journal-title":"Clinics (Sao Paulo)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz P","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, et al.. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018, 18:95-107. 10.1016\/S1473-3099(17)30592-3","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.25259\/JLP_231_2024","article-title":"Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) counts in distinguishing between bacterial and viral infections in acute respiratory tract infections","volume":"17","author":"Ramakrishnan V","year":"2025","unstructured":"Ramakrishnan V, Datchanamoorthy M, Lakshmi SSJ, Gopinathan A, Leela KV. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) counts in distinguishing between bacterial and viral infections in acute respiratory tract infections. J Lab Physicians. 2025, 17:247-53.","journal-title":"J Lab Physicians"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-64068-8.00055-9","article-title":"How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?","author":"Binnie A","year":"2020","unstructured":"Binnie A, Lage J, Dos Santos CC. How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?. Evidence-Based Practice of Critical Care. 2020, 319-324.e1.","journal-title":"Evidence-Based Practice of Critical Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002928","article-title":"Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis","volume":"46","author":"Iankova I","year":"2018","unstructured":"Iankova I, Thompson-Leduc P, Kirson NY, et al.. Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis. Crit Care Med. 2018, 46:691-8. 10.1097\/CCM.0000000000002928","journal-title":"Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial","volume":"174","author":"Christ-Crain M","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R, et al.. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006, 174:84-93. 10.1164\/rccm.200512-1922OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay JP","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al.. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019, 200:e45-67. 10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis464","article-title":"Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis","volume":"55","author":"Schuetz P","year":"2012","unstructured":"Schuetz P, Briel M, Christ-Crain M, et al.. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012, 55:651-62. 10.1093\/cid\/cis464","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1747","article-title":"Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD","volume":"139","author":"Bafadhel M","year":"2011","unstructured":"Bafadhel M, Clark TW, Reid C, et al.. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2011, 139:1410-8. 10.1378\/chest.10-1747","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12704","article-title":"Prognostic value of procalcitonin in pneumonia: a systematic review and meta-analysis","volume":"21","author":"Liu D","year":"2016","unstructured":"Liu D, Su LX, Guan W, Xiao K, Xie LX. Prognostic value of procalcitonin in pneumonia: a systematic review and meta-analysis. Respirology. 2016, 21:280-8. 10.1111\/resp.12704","journal-title":"Respirology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24469.2","article-title":"The use of 'PICO for synthesis' and methods for synthesis without meta-analysis: protocol for a survey of current practice in systematic reviews of health interventions","volume":"9","author":"Cumpston MS","year":"2020","unstructured":"Cumpston MS, McKenzie JE, Thomas J, Brennan SE. The use of 'PICO for synthesis' and methods for synthesis without meta-analysis: protocol for a survey of current practice in systematic reviews of health interventions. F1000Res. 2020, 9:678. 10.12688\/f1000research.24469.2","journal-title":"F1000Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","unstructured":"McGuinness, LA, Higgins, JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Syn Meth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz P","year":"2009","unstructured":"Schuetz P, Christ-Crain M, Thomann R, et al.. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009, 302:1059-66. 10.1001\/jama.2009.1297","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain M","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, M\u00fcller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet. 2004, 363:600-7. 10.1016\/S0140-6736(04)15591-8","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.18.2000","article-title":"Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care","volume":"168","author":"Briel M","year":"2008","unstructured":"Briel M, Schuetz P, Mueller B, et al.. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008, 168:2000-7. 10.1001\/archinte.168.18.2000","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02709.x","article-title":"Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial","volume":"15","author":"Kristoffersen KB","year":"2009","unstructured":"Kristoffersen KB, S\u00f8gaard OS, Wejse C, et al.. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial. Clin Microbiol Infect. 2009, 15:481-7. 10.1111\/j.1469-0691.2009.02709.x","journal-title":"Clin Microbiol Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00053209","article-title":"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study","volume":"34","author":"Stolz D","year":"2009","unstructured":"Stolz D, Smyrnios N, Eggimann P, et al.. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009, 34:1364-75. 10.1183\/09031936.00053209","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00163309","article-title":"Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection","volume":"36","author":"Burkhardt O","year":"2010","unstructured":"Burkhardt O, Ewig S, Haagen U, et al.. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010, 36:601-7. 10.1183\/09031936.00163309","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002186","article-title":"Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial","volume":"3","author":"Annane D","year":"2013","unstructured":"Annane D, Maxime V, Faller JP, et al.. Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open. 2013, 3:e002186. 10.1136\/bmjopen-2012-002186","journal-title":"BMJ Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma L","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, et al.. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010, 375:463-74. 10.1016\/S0140-6736(09)61879-1","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial","volume":"16","author":"de Jong E","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, et al.. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial. Lancet Infect Dis. 2016, 16:819-27. 10.1016\/S1473-3099(16)00053-0","journal-title":"Lancet Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.03.027","article-title":"Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting","volume":"76","author":"Deliberato RO","year":"2013","unstructured":"Deliberato RO, Marra AR, Sanches PR, et al.. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis. 2013, 76:266-71. 10.1016\/j.diagmicrobio.2013.03.027","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/cc7903","article-title":"Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial","volume":"13","author":"Hochreiter M","year":"2009","unstructured":"Hochreiter M, K\u00f6hler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009, 13:R83. 10.1186\/cc7903","journal-title":"Crit Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318251517a","article-title":"Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients","volume":"40","author":"Layios N","year":"2012","unstructured":"Layios N, Lambermont B, Canivet JL, et al.. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med. 2012, 40:2304-9. 10.1097\/CCM.0b013e318251517a","journal-title":"Crit Care Med"},{"key":"ref30","article-title":"The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit","volume":"562","author":"Khajavi MR","year":"2015","unstructured":"Khajavi MR, Najafi A, Khodadadian A, et al.. The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran. 2015, 562:7.","journal-title":"Acta Med Iran"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1238OC","article-title":"Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial","volume":"177","author":"Nobre V","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008, 177:498-505. 10.1164\/rccm.200708-1238OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-008-0432-1","article-title":"Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study","volume":"394","author":"Schroeder S","year":"2009","unstructured":"Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009, 394:221-6. 10.1007\/s00423-008-0432-1","journal-title":"Langenbecks Arch Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1483OC","article-title":"Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial","volume":"190","author":"Shehabi Y","year":"2014","unstructured":"Shehabi Y, Sterba M, Garrett PM, et al.. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med. 2014, 190:1102-10. 10.1164\/rccm.201408-1483OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S104051","article-title":"Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD","volume":"11","author":"Corti C","year":"2016","unstructured":"Corti C, Fally M, Fabricius-Bjerre A, et al.. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2016, 11:1381-9. 10.2147\/COPD.S104051","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref35","article-title":"The value of serum procalcitonin level in guiding the use of antibiotic in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"40","author":"Liu S-S","year":"2015","unstructured":"Liu S-S, Zhang Y-B. The value of serum procalcitonin level in guiding the use of antibiotic in patients with acute exacerbation of chronic obstructive pulmonary disease. 2015, 40:459-63."},{"key":"ref36","article-title":"Use of procalcitonin to guide the antibiotic therapy in patients with an acute exacerbation of COPD in a resource-limited setting: a case-control study","volume":"18","author":"Nangia V","year":"2012","unstructured":"Nangia V, Gandhi K. Use of procalcitonin to guide the antibiotic therapy in patients with an acute exacerbation of COPD in a resource-limited setting: a case-control study. Clin Microbiol Infect. 2012, 18:404.","journal-title":"Clin Microbiol Infect"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118241","article-title":"Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial","volume":"10","author":"Verduri A","year":"2015","unstructured":"Verduri A, Luppi F, D'Amico R, et al.. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial. PLoS One. 2015, 10:e0118241. 10.1371\/journal.pone.0118241","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.04.024","article-title":"Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial","volume":"48","author":"Wang JX","year":"2016","unstructured":"Wang JX, Zhang SM, Li XH, Zhang Y, Xu ZY, Cao B. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. Int J Infect Dis. 2016, 48:40-5. 10.1016\/j.ijid.2016.04.024","journal-title":"Int J Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5141-9","article-title":"Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study","volume":"44","author":"Daubin C","year":"2018","unstructured":"Daubin C, Valette X, Thiolli\u00e8re F, et al.. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study. Intensive Care Med. 2018, 44:428-37. 10.1007\/s00134-018-5141-9","journal-title":"Intensive Care Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007498.pub3","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"10","author":"Schuetz P","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R, et al.. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017, 10:CD007498. 10.1002\/14651858.CD007498.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0338-6","article-title":"Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis","volume":"7","author":"Huang HB","year":"2017","unstructured":"Huang HB, Peng JM, Weng L, Wang CY, Jiang W, Du B. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis. Ann Intensive Care. 2017, 7:114. 10.1186\/s13613-017-0338-6","journal-title":"Ann Intensive Care"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04677-2","article-title":"Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis","volume":"27","author":"Papp M","year":"2023","unstructured":"Papp M, Kiss N, Baka M, et al.. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis. Crit Care. 2023, 27:394. 10.1186\/s13054-023-04677-2","journal-title":"Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502149-procalcitonin-guided-strategies-for-reducing-antibiotic-use-in-cap-hap-vap-and-copd-insights-from-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:08:59Z","timestamp":1785906539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502149-procalcitonin-guided-strategies-for-reducing-antibiotic-use-in-cap-hap-vap-and-copd-insights-from-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.113973","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}